Bill Rastetter

(Dr. William Rastetter Ph.D.)

Currently holds positions in Neurocrine Biosciences Inc, Fate Therapeutics Inc, Regulus Therapeutics Inc and Dare Bioscience Inc

Positions

Position Company Period
Independent Chairman of the Board Neurocrine Biosciences Inc May 1, 2011 -
Independent Chairman of the Board Fate Therapeutics Inc Nov. 1, 2011 -
Independent Director Regulus Therapeutics Inc April 1, 2013 -
Lead Independent Director Dare Bioscience Inc None -
Independent Chairman of the Board Illumina Inc Jan. 27, 2005 - Jan. 28, 2016
Bill Rastetter's trades of Neurocrine Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-16 2024-08-15
S Sale
14,250 -27.5%
146.69
USD 2,090,333 		14,250 -27.5% 146.69 USD 2,090,333
2024-01-04 2024-01-02
PS Planned sale
11,044 -17.6%
131.47
USD 1,451,927 		11,044 -17.6% 131.47 USD 1,451,927
2023-05-03 2023-05-01
PS Planned sale
4,300 -9.1%
101.43
USD 436,135 		4,300 -9.1% 101.43 USD 436,135
2023-04-21 2023-04-21
PS Planned sale
6,034 -13.3%
105.04
USD 633,787 		6,034 -13.3% 105.04 USD 633,787
2023-04-21 2023-04-19
PS Planned sale
903 -2.5%
105.00
USD 94,819 		903 -2.5% 105.00 USD 94,819
2022-04-05 2022-04-01
PS Planned sale
10,728 -24.0%
94.93
USD 1,018,366 		10,728 -24.0% 94.93 USD 1,018,366
2019-05-08 2019-05-07
B Purchase
92,889 +151.4%
1.08
USD 100,320 		92,889 +151.4% 1.08 USD 100,320
2017-07-25 2017-07-25
B Purchase
274,725 +78.5%
0.91
USD 250,000 		274,725 +78.5% 0.91 USD 250,000
2017-03-07 2017-03-07
B Purchase
250,000 +250.0%
1.15
USD 287,500 		250,000 +250.0% 1.15 USD 287,500
2004-05-26 2004-05-24
US Biogen Inc (BIIB)
S Sale
29,081 -26.9%
62.51
USD 1,817,714 		29,081 -26.9% 62.51 USD 1,817,714
2004-05-20 2004-05-19
US Biogen Inc (BIIB)
S Sale
25,000 -18.8%
60.03
USD 1,500,750 		25,000 -18.8% 60.03 USD 1,500,750
2004-05-06 2004-05-04
US Biogen Inc (BIIB)
S Sale
25,000 -13.5%
58.83
USD 1,470,750 		25,000 -13.5% 58.83 USD 1,470,750
2004-05-06 2004-05-04
US Biogen Inc (BIIB)
S Sale
80,000 -47.2%
58.68
USD 4,694,400 		80,000 -47.2% 58.68 USD 4,694,400
2004-05-06 2004-05-04
US Biogen Inc (BIIB)
S Sale
25,000 -12.8%
58.83
USD 1,470,750 		25,000 -12.8% 58.83 USD 1,470,750
// ... existing code ... // ... rest of the file ...